Canada markets closed

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.2100-0.0700 (-5.47%)
At close: 04:00PM EST
1.2000 -0.01 (-0.83%)
After hours: 06:55PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.2800
Open1.2800
Bid1.1800 x 1200
Ask1.2200 x 1200
Day's Range1.1700 - 1.2990
52 Week Range1.0400 - 9.7600
Volume503,614
Avg. Volume1,604,354
Market Cap53.871M
Beta (5Y Monthly)1.42
PE Ratio (TTM)N/A
EPS (TTM)-0.4640
Earnings DateFeb. 07, 2022 - Feb. 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.99
  • GlobeNewswire

    Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference

    LAVAL, Québec, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D’Alvise, President and CEO of Acasti, will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13, 2022. Acasti’s presentation will be available on-demand to registered attendees via the conference platform beginning Monday, January 10, 2022 at 7:00 AM Eastern Time. The webcast of the Company’s presen

  • Simply Wall St.

    Market Sentiment Around Loss-Making Acasti Pharma Inc. (CVE:ACST)

    With the business potentially at an important milestone, we thought we'd take a closer look at Acasti Pharma Inc.'s...

  • GlobeNewswire

    Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104

    Bioavailability of GTX-104 compares favorably with the oral formulation of nimodipine; full PK study expected to report out as planned in H1’22LAVAL, Québec, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced positive results for GTX-104 based on its interim analysis of the first 20 of 50 normal healthy subjects in its pivotal pharmacokinetic (PK) bridging study. GTX-104 met both primary endpoints for Maximum Concentra